1. Home
  2. ELTX vs ROC Comparison

ELTX vs ROC Comparison

Compare ELTX & ROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo Rank One Computing Corporation Common stock

ROC

Rank One Computing Corporation Common stock

N/A

Current Price

$3.62

Market Cap

71.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
ROC
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
71.2M
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
ELTX
ROC
Price
$1.90
$3.62
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
★ $13.67
$7.75
AVG Volume (30 Days)
★ 258.8K
25.4K
Earning Date
11-12-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
N/A
★ N/A
Revenue
$2,301,000.00
★ $16,979,679.00
Revenue This Year
N/A
$21.30
Revenue Next Year
N/A
$72.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 23.90
52 Week Low
$1.44
$3.35
52 Week High
$16.00
$7.80

Technical Indicators

Market Signals
Indicator
ELTX
ROC
Relative Strength Index (RSI) 48.08 41.05
Support Level $1.74 N/A
Resistance Level $1.97 $4.59
Average True Range (ATR) 0.15 0.28
MACD 0.04 -0.01
Stochastic Oscillator 79.63 38.42

Price Performance

Historical Comparison
ELTX
ROC

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About ROC Rank One Computing Corporation Common stock

Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.

Share on Social Networks: